Clinical Trial Update: A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating MK0476 in combination with Fluticasone for mild persistent asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone (fluticasone propionate)
• MK0476

Snippet

Sponsor: Organon and Co | Conditions: Asthma, Bronchial | Phase 3 | Status: COMPLETED